A fire in a Mumbai chawl killed a 15-year-old boy and injured three others. The blaze, limited to a small area, was quickly controlled. The cause is under investigation., Mumbai News, Times Now ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback